AbbVie Non-GAAP EPS of $2.97 beats by $0.06, revenue of $15.42B beats by $390M

22 hours ago 1

AbbVie press release (NYSE:ABBV): Q2 Non-GAAP EPS of $2.97 beats by $0.06.
Revenue of $15.42B (+6.6% Y/Y) beats by $390M.
Second-Quarter Global Net Revenues from the Immunology Portfolio Were $7.631 Billion, an Increase of 9.5 Percent on a Reported Basis, or 9.2 Percent

Recommended For You